Author Topic: (Abst.) Early treatment delays long-term disability accrual in RRMS  (Read 22 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9480
  • MS diagnosed 1980
  • Location: Pacific Northwest
Experts are saying more and more often that the disease-modifying drugs work best when prescribed soon after the onset of MS. On the other hand, doctors hesitate to diagnose MS because it is such a difficult disease to diagnose, and so many wait until time passes and they will have had a chance to observe the patient over time.  Rushing to prescribe a DMT for someone who has a disorder that isn't MS seems very unwise.

This abstract is from Multiple Sclerosis Journal (April 26, 2021), "Early treatment delays long-term disability accrual in RRMS:  Results from the BMSD Network":
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.


Related Topics

  Subject / Started by Replies Last post
0 Replies
Last post June 13, 2016, 08:20:12 am
by agate
0 Replies
Last post June 14, 2018, 11:10:36 am
by agate
0 Replies
Last post June 08, 2019, 09:32:13 am
by agate
0 Replies
Last post September 06, 2021, 09:10:08 pm
by agate
1 Replies
Last post June 09, 2022, 09:32:47 pm
by agate